Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,052,600 | 1,444,300 | 1,158,800 | 733,800 | 817,600 |
| Marketable Securities | 1,678,600 | 1,253,600 | 1,426,100 | 1,898,800 | 1,890,100 |
| Receivables | 514,300 | 529,100 | 483,500 | 443,400 | 428,500 |
| Inventories | 357,300 | 351,300 | 319,300 | 289,700 | 234,700 |
| TOTAL | $3,684,400 | $3,656,200 | $3,474,200 | $3,445,100 | $3,424,800 |
| Non-Current Assets | |||||
| PPE Net | 801,800 | 742,200 | 676,000 | 589,900 | 515,300 |
| Intangibles | 58,000 | 23,900 | 19,100 | 18,900 | 40,700 |
| Other Non-Current Assets | 389,100 | 353,600 | 334,500 | 335,900 | 309,700 |
| TOTAL | $1,248,900 | $1,119,700 | $1,029,600 | $944,700 | $865,700 |
| Total Assets | $4,933,300 | $4,775,900 | $4,503,800 | $4,389,800 | $4,290,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 573,000 | 598,000 | 482,000 | 502,600 | 481,100 |
| Accrued Expenses | 125,200 | 115,300 | 98,100 | 81,400 | 114,300 |
| TOTAL | $720,800 | $734,900 | $600,700 | $604,100 | $614,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,981,800 | 1,703,500 | 1,710,700 | 1,688,800 | 1,667,200 |
| Deferred Revenues | 2,100 | 2,300 | 1,800 | 1,900 | 2,200 |
| Other Non-Current Liabilities | 188,600 | 201,400 | 194,800 | 193,700 | 182,700 |
| TOTAL | $2,170,400 | $1,904,900 | $1,905,500 | $1,882,500 | $1,849,900 |
| Total Liabilities | $2,891,200 | $2,639,800 | $2,506,200 | $2,486,600 | $2,464,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 388,263 | 387,688 | 386,996 | 386,824 | 384,709 |
| Common Shares | 400 | 100 | 100 | 100 | 100 |
| Retained earnings | 138,700 | -28,000 | -98,900 | -161,800 | -202,100 |
| Other shareholders' equity | 300 | 1,900 | 2,800 | 2,900 | 3,200 |
| TOTAL | $2,042,100 | $2,136,100 | $1,997,600 | $1,903,200 | $1,826,500 |
| Total Liabilities And Equity | $4,933,300 | $4,775,900 | $4,503,800 | $4,389,800 | $4,290,500 |